BSE filing, NSE: STLTECH. Summary written from the filing by ALFA Finder's alert engine.
Sterlite Technologies Ltd: key numbers
- Share price
- ₹879.40
- Market cap
- ₹45,206 Cr
- Revenue (annual)
- ₹4,745 Cr
- Net profit (annual)
- ₹56.00 Cr
- P/E (TTM)
- 59.8×Sector 57.7×
- Promoter holding
- 42.28%-2.23% QoQ
- FII holding
- 17.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sterlite Technologies Ltd
All →Sterlite Technologies Earnings Call Transcript: Key Takeaways
Record Q2 revenue of ₹2,529 Cr (+145% YoY) with 27% operational EBITDA margin; FY29 margin target lifted to 30%. Reported EBITDA and PAT include a one-time ₹161 Cr tariff refund.
Sterlite Technologies Other Announcement
Sterlite Technologies filed its quarterly Monitoring Agency report (Q2 FY27) for the Rs.498.30 Cr Prefential Warrants issue. CARE Ratings confirmed NIL deviation from stated objects of use.
Sterlite Technologies Q2 FY27 Results: Net Profit ₹517 Cr, Up 12825.0% YoY
Sterlite Technologies Ltd reported revenue from operations of ₹2,529 Cr (+144.6% YoY) and net profit of ₹517 Cr (+12825.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹517 Cr · +12825.0% YoY
Sterlite Technologies Other Announcement
Sterlite Technologies Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Sterlite Technologies Board Meeting Date
Sterlite Technologies Limited has scheduled a board meeting on October 23, 2026, to consider the unaudited financial results for the quarter and half year ended September 30, 2026.
Sterlite Technologies Bags ₹11,400 Cr Order from A hyperscale partner
Sterlite Technologies Limited's subsidiary secured a Long-Term Supply Agreement from an international hyperscale partner. The contract is valued at approximately USD 1.2 billion for connectivity products.
- Value
- ₹11,400 Cr
- From
- A hyperscale partner
- Execution
- CY26 to CY30
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date